LiveRamp Posts 10% Revenue Growth in Q1 FY27, Publicis Deal on Track

What happened

LiveRamp reported first-quarter fiscal 2027 revenue of roughly $199 million, up 10% year-over-year, with GAAP operating income more than doubling and non-GAAP operating income surging 41%. The company attributed the profit jump to continued operating leverage and cost discipline. Management reiterated that the pending acquisition by Publicis Groupe remains on track to close before the end of calendar 2026, and as a result, LiveRamp did not host a conference call or provide forward guidance. The stand-alone results show steady execution, but the near-term investment case is now entirely tied to the deal’s completion. With the merger agreement in place, the stock will likely trade in a tight spread around the implied deal price, limiting both downside and upside until close.

Implication

For current shareholders, the primary value driver is the certainty and timing of the Publicis acquisition, as the market will narrow the spread to the deal price as closure approaches. The solid Q1 results—10% top-line growth and strong margin expansion—demonstrate that the underlying business is performing well, which reduces the risk of deal termination or renegotiation. However, with no guidance and management’s focus on closing, standalone upside is capped, and the stock becomes a merger arbitrage play. Key risks include regulatory delays or an unexpected breakup, though both appear low given the reiteration of the timeline. Investors should weigh the premium offered against the time to close, while keeping an eye on any material deterioration in LiveRamp’s operating trends that could affect the deal’s certainty.

Thesis delta

The previous WAIT rating was based on modest stand-alone growth and valuation multiples. The announced acquisition by Publicis Groupe fundamentally shifts the thesis: the stock is now a merger arbitrage situation where the outcome depends on deal completion rather than fundamental execution. As long as the transaction remains on track, the share price will converge toward the deal value, rendering the prior stand-alone valuation framework irrelevant.